Key Financial Data Of Reporting Company

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7305469

Concept As at
2024-08-31
2024-03-01 to
2024-08-31
2023-03-01 to
2024-02-29
As at
2024-02-29
2023-03-01 to
2023-08-31
As at
2023-08-31
Key financial data of reporting company
Business results of reporting company
Net sales
75,456,000,000 JPY
141,706,000,000 JPY
66,977,000,000 JPY
Ordinary profit (loss)
10,788,000,000 JPY
19,649,000,000 JPY
11,640,000,000 JPY
Net assets
275,927,000,000 JPY
267,082,000,000 JPY
275,108,000,000 JPY
Total assets
350,477,000,000 JPY
328,779,000,000 JPY
344,300,000,000 JPY
Basic earnings (loss) per share
122.71
181.62
108.34
Diluted earnings per share
122.55
181.42
108.23
Equity-to-asset ratio
0.780 xbrli:pure
0.805 xbrli:pure
0.792 xbrli:pure
Net cash provided by (used in) operating activities
8,256,000,000 JPY
18,188,000,000 JPY
7,851,000,000 JPY
Net cash provided by (used in) investing activities
4,242,000,000 JPY
-2,512,000,000 JPY
10,443,000,000 JPY
Net cash provided by (used in) financing activities
-12,350,000,000 JPY
-16,691,000,000 JPY
-4,841,000,000 JPY
Cash and cash equivalents
68,617,000,000 JPY
66,366,000,000 JPY
81,186,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.